Skip to main content

Naproxen

NDC 50268-595 · AvPAK

Generic nameNaproxen
Dosage formTABLET
RouteORAL
Active ingredient(s)NAPROXEN
Strength375 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

50268-595-15 — 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-595-15) / 1 TABLET in 1 BLISTER PACK (50268-595-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-6762 — Naproxen, 50090-6980 — Naproxen, 50090-7198 — Naproxen, 50090-7676 — Naproxen, 50228-434 — Naproxen, 50228-435 — Naproxen, 50228-436 — Naproxen, 50228-437 — Naproxen and esomeprazole magnesium, 50228-438 — Naproxen and esomeprazole magnesium, 50268-594 — Naproxen, 51655-363 — Naproxen, 51655-457 — Naproxen, 51655-621 — NAPROXEN, 51655-657 — Naproxen, 51655-743 — Naproxen, 52817-380 — Naproxen, 52817-381 — Naproxen, 53746-188 — Naproxen, 53746-189 — Naproxen, 53746-190 — Naproxen, +171 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels